Lupus update: perspective and clinical pearls.
Patients with systemic lupus erythematosus (SLE, lupus) have a markedly better survival rate today than they did 50 years ago, but they face a greater risk of cancer, cardiovascular disease, and osteoporosis at early ages. With better understanding of the immunological mechanisms of the disease, new avenues of therapy are emerging.
Director, Patient Care and Translational Research, Lupus Center of Excellence, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA 15261, USA. firstname.lastname@example.org
Lupus Erythematosus, Systemic
Pub Type(s)Journal Article